Study finds jabs cut severe variant COVID disease after one shotA real-world study carried out in Canada has found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce Share XStudy finds jabs cut severe variant COVID disease after one shothttps://pharmaphorum.com/news/study-finds-jabs-cut-severe-variant-covid-disease-after-one-shot/
Happify launches Ensemble DTx for depression, anxiety in USHappify Health has launched a prescription digital therapeutic (DTx) – called Ensemble – that can assist the treatment Share XHappify launches Ensemble DTx for depression, anxiety in UShttps://pharmaphorum.com/news/happify-launches-ensemble-dtx-for-depression-anxiety-in-us/
Pfizer puts up $1bn to buy into Arvinas breast cancer programmePfizer has pledged a whopping $1 billion upfront for rights to an Arvinas drug for breast cancer from Share XPfizer puts up $1bn to buy into Arvinas breast cancer programmehttps://pharmaphorum.com/news/pfizer-puts-up-1bn-to-buy-into-arvinas-breast-cancer-programme/
COVID-19: Celltrion’s therapeutic optionIn just over a year, Celltrion Healthcare says it has identified and delivered a potential treatment for COVID-19. Share XCOVID-19: Celltrion’s therapeutic optionhttps://pharmaphorum.com/r-d/covid-19-providing-a-therapeutic-option/
Oncology and a year of COVID: lessons for the futureCOVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up Share XOncology and a year of COVID: lessons for the futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-and-a-year-of-covid-lessons-for-the-future/
Ten tips on pharma time managementOliver Stohlmann’s new Corporate Survival Hacks series draws on his experiences of working in local, regional and global Share XTen tips on pharma time managementhttps://pharmaphorum.com/views-and-analysis/ten-tips-on-pharma-time-management/
Digital tools key to immuno-oncology’s future: reportIf ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows Share XDigital tools key to immuno-oncology’s future: reporthttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/digital-tools-key-to-immuno-oncology-future-report/
Oncology and a year of COVID: lessons for the futureCOVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up Share XOncology and a year of COVID: lessons for the futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-and-a-year-of-covid-lessons-for-the-future/
How hybrid virtual engagement is accelerating oncology communicationCOVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement Share XHow hybrid virtual engagement is accelerating oncology communicationhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/how-hybrid-virtual-engagement-is-accelerating-oncology-communication/
Using AI to make a big impact for emerging and mid-sized biopharma companies Share XUsing AI to make a big impact for emerging and mid-sized biopharma companieshttps://pharmaphorum.com/webinars/using-ai-to-make-a-big-impact-for-emerging-and-mid-sized-biopharma-companies/
The digital transformation of pharma’s physician engagement strategies Share XThe digital transformation of pharma’s physician engagement strategieshttps://pharmaphorum.com/webinars/digital-transformation-pharma-engagement-p360/
Customer engagement and pharma’s field force future Share XCustomer engagement and pharma’s field force futurehttps://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/
4 ways to embed data-driven best practice in pharma HCP communicationsVirtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for Share X4 ways to embed data-driven best practice in pharma HCP communicationshttps://pharmaphorum.com/whitepapers/4-ways-to-embed-data-driven-best-practice-in-pharma-hcp-communications/
A digital health roadmap for pharma, medical devices and insurance techCOVID-19 has massively accelerated the uptake of digital health technology across the whole ecosystem, with important implications for Share XA digital health roadmap for pharma, medical devices and insurance techhttps://pharmaphorum.com/whitepapers/digital-health-roadmap-pharma-medical-devices-insurance/
Plugging modular content into pharma’s omnichannel strategies86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a Share XPlugging modular content into pharma’s omnichannel strategieshttps://pharmaphorum.com/whitepapers/plugging-modular-content-into-pharmas-omnichannel-strategies/
Health Innovators – Jo Brewer, Adaptimmune Share XHealth Innovators – Jo Brewer, Adaptimmunehttps://pharmaphorum.com/video/health-innovators-jo-brewer-adaptimmune/
Health Innovators: Eliot Forster, F-Star Share XHealth Innovators: Eliot Forster, F-Starhttps://pharmaphorum.com/views-analysis-oncology/health-innovators-eliot-forster-f-star/
Pharmacy and clinical research: the pharmaphorum podcast Share XPharmacy and clinical research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharmacy-clinical-research-rxe2/
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor Share XThe key to psoriasis innovation? Dispelling the shadow of the JAK inhibitorhttps://pharmaphorum.com/partner-content/the-key-to-psoriasis-innovation-dispelling-the-shadow-of-the-jak-inhibitor/
Complex Medicines: A multi-billion-pound addition to the UK life sciences industry Share XComplex Medicines: A multi-billion-pound addition to the UK life sciences industryhttps://pharmaphorum.com/partner-content/complex-medicines-a-multi-billion-pound-addition-to-the-uk-life-sciences-industry/
PRIYSM ID boosts customer service offer with new customer experience team Share XPRIYSM ID boosts customer service offer with new customer experience teamhttps://pharmaphorum.com/partner-content/priysm-id-boosts-customer-service-offer-with-new-customer-experience-team/
KOL Mindset Mapping Share XKOL Mindset Mappinghttps://pharmaphorum.com/partner-content/kol-mindset-mapping/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
Prescient Announces Recent Appointments to its Senior Team Share XPrescient Announces Recent Appointments to its Senior Teamhttps://pharmaphorum.com/partner-content/prescient-announces-recent-appointments-to-its-senior-team/
